Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2006; 12(5): 739-746
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.739
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.739
Table 1 Incidence of abnormal microproteinuria in patients with active and inactive IBD (%)
| Ulcerative colitis (n = 194) | Crohn's disease (n = 83) | |||||
| Active (n = 49)UCAI ≥ 6 | Inactive (n = 145)UCAI < 6 | P | Active (n = 15)CDAI ≥ 150 | Inactive (n = 68)CDAI < 150 | P | |
| Urine m-ALB (>18 μg/min) | 16.3 | 11.7 | NS | 13.3 | 4.4 | 0.06 |
| Urine β2 mGLB (>120 μg/min) | 40.8 | 16.6 | < 0.001 | 53.3 | 22.1 | < 0.05 |
| Urine β-NAG (>5.9 U/L) | 26.5 | 6.2 | < 0.001 | 13.3 | 7.4 | NS |
- Citation: Poulou AC, Goumas KE, Dandakis DC, Tyrmpas I, Panagiotaki M, Georgouli A, Soutos DC, Archimandritis A. Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J Gastroenterol 2006; 12(5): 739-746
- URL: https://www.wjgnet.com/1007-9327/full/v12/i5/739.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i5.739